The ERLIN1 gene helps cells control and clear certain proteins inside the endoplasmic reticulum, a part of the cell that processes proteins. This gene plays an important role in keeping calcium signals balanced and supporting healthy nerve cells. If you carry harmful variants that greatly reduce ERLIN1 function, you may develop inherited nerve problems such as increasing leg stiffness and weakness, trouble walking, and sometimes developmental or speech difficulties. ERLIN1 is mainly known in rare disease genetics rather than in public culture.
What is a gene?
A gene is a section of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for making proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they occur, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To look into this topic more closely, you can read more in the LearnHub.
Overview
ERLIN1Gene function
What if the gene works
The ERLIN1 gene helps cells manage certain proteins in the endoplasmic reticulum, a cell compartment that folds and processes proteins. It also supports calcium signals, which help nerve and muscle cells work normally.
Risk
What if the gene does not work
Variants that reduce the ERLIN1 gene's function are linked to a rare inherited nerve condition with leg stiffness and walking problems. Some people also have developmental delay or seizures. Milder and more severe variants can influence onset and severity.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the ERLIN1 gene is currently established.
Conditions associated with ERLIN1
Gene function
What if the gene works
The ERLIN1 gene helps your cells with routine protein housekeeping inside the endoplasmic reticulum, the part of the cell that folds and processes proteins. It works in a small membrane complex that sorts certain proteins for removal when they have finished their job. This everyday role explains how the ERLIN1 gene helps cells manage proteins and steady cell signals.
The ERLIN1 gene helps manage proteins in the endoplasmic reticulum, the part of the cell that folds and processes many proteins. Its protein works in the membrane as part of a small team that recognizes proteins ready for routine turnover.
It helps guide selected proteins into ER associated degradation, a cleanup pathway that removes proteins the cell no longer needs. This keeps protein processing more organized and supports normal cell housekeeping.
One important target is the IP3 receptor, a channel that releases calcium inside cells when signals arrive. By helping control how much of this channel stays in the membrane, the ERLIN1 gene supports balanced cell signaling.
Its protein gathers in small cholesterol rich areas of the endoplasmic reticulum membrane. These work zones help bring the right proteins together so sorting and removal can happen in an orderly way.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ERLIN1 gene can lower the amount of ERLIN1 made, alter its shape, or weaken its link with partner proteins in the cell’s protein quality control system. This is how ERLIN1 gene variants affect protein function at the cell level, often making the protein less stable or less able to form its usual complex. Milder missense variants may leave some activity, while more disruptive variants can cause little or no working protein. In ERLIN1 related neurologic disease, that difference can influence how early features appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the ERLIN1 gene cause a rare autosomal recessive form of hereditary spastic paraplegia called SPG62. Variants in the ERLIN1 gene linked to hereditary spastic paraplegia usually lead to gradually increasing leg stiffness and weakness, and some people also have delayed development or other neurologic features. When disease-causing variants are found in both copies of the ERLIN1 gene, this can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply contribute to natural human variation. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the ERLIN1 gene. In families with an ERLIN1 change, the main factor is whether that genetic change is present, while symptoms and severity can still vary from one person to another.
Inheritance of ERLIN1 variants
ERLIN1-related conditions are inherited in an autosomal recessive pattern. In plain terms, ERLIN1 gene inheritance usually means a person has to receive one altered copy of the ERLIN1 gene from each parent to be affected. Parents who each carry one variant are often unaffected themselves, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two usual copies of the gene. Sons and daughters are affected at similar rates.
What does my ERLIN1 result mean for my family?
For ERLIN1, the best-established family pattern is recessive, which usually means parents are healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same ERLIN1 change runs in the family, especially when there is a history of walking stiffness or weakness. Children of someone with an ERLIN1-related condition usually inherit one changed copy and are carriers unless the other parent also carries an ERLIN1 change.
Genetic information
Genetic testing
How you find out about variants
ERLIN1 genetic testing looks for changes in the ERLIN1 gene using a blood sample or cheek swab. A lab reads the DNA and compares it with the usual sequence to identify variants. Results can help confirm a genetic diagnosis or clarify whether a variant is benign, pathogenic, or uncertain.
When should I consider getting a genetic test?
Genetic testing may be worth considering with unexplained, slowly worsening leg stiffness or weakness, trouble walking, or a family history of a rare inherited nerve condition linked to the ERLIN1 gene. It can help clarify whether ERLIN1 is part of the cause and whether close relatives may also be at risk.
A genetic result is only one part of your health story
Genetic results can be informative, yet how much they reveal varies by the condition and the type of variant involved. Many factors also shape how the body works over time, including age, environment, lifestyle, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results may help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for one person than for another. This is common and can influence how much benefit a medicine provides or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It focuses on links between genes and drugs to help explain why the same treatment may not work the same way for everyone. With many medications, genes can influence both how strong a drug’s effect is and how the body handles it. Understanding this can support treatment choices that are better informed and more personalized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the ERLIN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so medication side effects, treatment questions, or other health concerns are best discussed with your doctor.